Business Insider1d
Biogen price target raised to $300 from $294 at Baird
Baird raised the firm’s price target on Biogen (BIIB) to $300 from $294 and keeps an Outperform rating on the shares. The firm said Biogen partner Eisai’s request for the EMA’s CHMP to reexamine the ...
pharmaphorum2d
Whistleblower gets $250m as Biogen settles US kickbacks case
Biogen will pay $844 million to the US government and another $56 million to 15 states within the next 20 days, with Bawduniak in line to pocket a share of the federal recovery – a sum of $250 ...
Business Insider23h
Biogen (BIIB) Gets a Buy from TD Cowen
TD Cowen analyst Phil Nadeau maintained a Buy rating on Biogen (BIIB – Research Report) today and set a price target of $275.00. The company’s shares closed yesterday at $164.89. According to TipRanks ...
Biogen Inc. (NASDAQ:BIIB) Holdings Decreased by US Bancorp DE
US Bancorp DE reduced its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 15.7% in the third quarter, according ...